Kasabach-Merritt syndrome (Q92985): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
A síndrome de Kasabach-Merritt é caracterizada pela associação de um tumor vascular com trombocitopenia grave e vários graus de coagulopatia de consumo (mais comumente marcada por níveis diminuídos de fibrinogênio, presença de níveis elevados de complexos solúveis e níveis muito elevados de dímeros D). | |||
| description / en | description / en | ||
Kasabach-Merritt syndrome is characterised by the association of a vascular tumour with severe thrombopaenia and various degrees of consumption coagulopathy (most commonly marked by decreased levels of fibrinogen, presence of elevated levels of soluble complexes, and very high levels of D-dimers). | |||
Revision as of 08:06, 16 August 2026
Kasabach-Merritt syndrome is characterised by the association of a vascular tumour with severe thrombopaenia and various degrees of consumption coagulopathy (most commonly marked by decreased levels of fibrinogen, presence of elevated levels of soluble complexes, and very high levels of D-dimers).
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_2059601885 |
||
| English | Kasabach-Merritt syndrome |
Kasabach-Merritt syndrome is characterised by the association of a vascular tumour with severe thrombopaenia and various degrees of consumption coagulopathy (most commonly marked by decreased levels of fibrinogen, presence of elevated levels of soluble complexes, and very high levels of D-dimers). |
